CELL INTELLIGENCE · 肿瘤细胞治疗研究

脐带血来源 CAR-NK 细胞：肿瘤免疫治疗的新兴即用型平台

Umbilical cord blood-derived CAR-NK cells: an emerging off-the-shelf platform for cancer immunotherapy.

烟酰胺单核苷酸增强靶向 MSLN 的 CAR-NK 细胞治疗在卵巢癌中的抗肿瘤疗效

Nicotinamide mononucleotide potentiates the anti-tumor efficacy of CAR-NK cell therapy targeting MSLN in ovarian cancer.

嵌合抗原受体自然杀伤（CAR-NK）细胞治疗乳腺癌的疗效与安全性评价：系统综述与荟萃分析

Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.

胰腺癌新兴嵌合抗原受体免疫细胞治疗：机制、临床进展与未来展望

Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives.

嵌合抗原受体 NK 细胞治疗卵巢癌的疗效：临床前研究的荟萃分析

Efficacy of chimeric antigen receptor natural killer cells in treatment of ovarian cancer. A meta-analysis of pre-clinical studies.

CD33(KO)-CD33-mesothelin Loop CAR 设计避免自相残杀并提高 iNK 细胞抗急性髓系白血病的疗效

CD33(KO)-CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia.

Loop CAR 赋予 UCB-NK 细胞和 hPSC-iNK 细胞更强的针对 CD33 + MSLN + 肿瘤细胞的细胞毒性。

嵌合抗原受体 NK 细胞用于乳腺癌免疫治疗

Chimeric antigen receptor NK cells for breast cancer immunotherapy.

Neoleukin-2/15 装甲 CAR-NK 细胞通过 c-Myc/NRF1 激活在实体瘤中维持优越的治疗效果

Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation.

人胚胎干细胞来源的间皮素 CAR 工程化 NK 细胞抑制动物体内人卵巢癌进展

Mesothelin CAR-engineered NK cells derived from human embryonic stem cells suppress the progression of human ovarian cancer in animals.

源自诱导多能干细胞的间皮素靶向 CAR-NK 细胞在多种临床前模型中高效杀伤三阴性乳腺癌细胞

Mesothelin-targeted CAR-NK Cells Derived From Induced Pluripotent Stem Cells Have a High Efficacy in Killing Triple-negative Breast Cancer Cells as Sh